These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 7632359)
1. p53 immunoreactivity in astrocytomas and its relationship to survival. al-Sarraj S; Bridges LR Br J Neurosurg; 1995 Apr; 9(2):143-9. PubMed ID: 7632359 [TBL] [Abstract][Full Text] [Related]
2. Role of gemistocytes in astrocytoma progression. Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164 [TBL] [Abstract][Full Text] [Related]
3. MIB1 and p53 immunoreactivity in protoplasmic astrocytomas. Prayson RA; Estes ML Pathol Int; 1996 Nov; 46(11):862-6. PubMed ID: 8970195 [TBL] [Abstract][Full Text] [Related]
4. Expression and mutation analysis of the p53 gene in astrocytoma. Hwang SL; Hong YR; Sy WD; Chai CY; Lin HJ; Howng SL J Formos Med Assoc; 1999 Jan; 98(1):31-8. PubMed ID: 10063271 [TBL] [Abstract][Full Text] [Related]
5. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140 [TBL] [Abstract][Full Text] [Related]
6. bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status. Newcomb EW; Bhalla SK; Parrish CL; Hayes RL; Cohen H; Miller DC Acta Neuropathol; 1997 Oct; 94(4):369-75. PubMed ID: 9341939 [TBL] [Abstract][Full Text] [Related]
7. Comparative study of p53 gene and protein alterations in human astrocytic tumors. Louis DN; von Deimling A; Chung RY; Rubio MP; Whaley JM; Eibl RH; Ohgaki H; Wiestler OD; Thor AD; Seizinger BR J Neuropathol Exp Neurol; 1993 Jan; 52(1):31-8. PubMed ID: 8381161 [TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Jaros E; Perry RH; Adam L; Kelly PJ; Crawford PJ; Kalbag RM; Mendelow AD; Sengupta RP; Pearson AD Br J Cancer; 1992 Aug; 66(2):373-85. PubMed ID: 1503912 [TBL] [Abstract][Full Text] [Related]
9. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Sidransky D; Mikkelsen T; Schwechheimer K; Rosenblum ML; Cavanee W; Vogelstein B Nature; 1992 Feb; 355(6363):846-7. PubMed ID: 1311419 [TBL] [Abstract][Full Text] [Related]
12. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715 [TBL] [Abstract][Full Text] [Related]
13. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas. Cheng Y; Pang JC; Ng HK; Ding M; Zhang SF; Zheng J; Liu DG; Poon WS Histopathology; 2000 Nov; 37(5):437-44. PubMed ID: 11119125 [TBL] [Abstract][Full Text] [Related]
14. p53 protein and epidermal growth factor receptor expression in human astrocytomas. Kordek R; Biernat W; Alwasiak J; Maculewicz R; Yanagihara R; Liberski PP J Neurooncol; 1995 Oct; 26(1):11-6. PubMed ID: 8583240 [TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas. Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466 [TBL] [Abstract][Full Text] [Related]
16. Absence of p53 autoantibodies in sera from glioma patients. Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045 [TBL] [Abstract][Full Text] [Related]
17. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression? Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324 [TBL] [Abstract][Full Text] [Related]
18. Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas. Parhar P; Ezer R; Shao Y; Allen JC; Miller DC; Newcomb EW Brain Res Mol Brain Res; 2005 Jun; 137(1-2):98-103. PubMed ID: 15950766 [TBL] [Abstract][Full Text] [Related]
19. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. Reifenberger J; Ring GU; Gies U; Cobbers L; Oberstrass J; An HX; Niederacher D; Wechsler W; Reifenberger G J Neuropathol Exp Neurol; 1996 Jul; 55(7):822-31. PubMed ID: 8965097 [TBL] [Abstract][Full Text] [Related]
20. p53 allelic imbalance in astrocytoma detected using fluorescent PCR of microsatellite repeat polymorphisms. al-Sarraj S; Bridges LR; Cawkwell L; Lewis FA; Quirke P Neuropathol Appl Neurobiol; 1995 Aug; 21(4):344-51. PubMed ID: 7494603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]